177 related articles for article (PubMed ID: 37385935)
1. [Contributions and limitations of FISH analysis for the diagnosis of central nervous system tumors according to the 2021 WHO classification: Feedback from Sainte-Anne Hospital's Department of Neuropathology].
Tauziède-Espariat A; Tartar A; Mehdi L; Pucelle N; Lacombe J; Berthaud C; Brigot E; Massé J; Métais A; Benzakoun J; Hasty L; Chrétien F; Varlet P
Ann Pathol; 2023 Nov; 43(6):443-451. PubMed ID: 37385935
[TBL] [Abstract][Full Text] [Related]
2. [The 2021 WHO classification of tumours of the central nervous system].
Figarella-Branger D; Appay R; Metais A; Tauziède-Espariat A; Colin C; Rousseau A; Varlet P
Ann Pathol; 2022 Oct; 42(5):367-382. PubMed ID: 34865882
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic DNA methylome profiling and the WHO 5
Frank S; Hench J
Clin Neuropathol; 2022; 41(4):153-156. PubMed ID: 35670246
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic, therapeutic, and prognostic implications of the 2021 World Health Organization classification of tumors of the central nervous system.
Gritsch S; Batchelor TT; Gonzalez Castro LN
Cancer; 2022 Jan; 128(1):47-58. PubMed ID: 34633681
[TBL] [Abstract][Full Text] [Related]
5. A Practical Approach to the Evaluation and Diagnosis of Pediatric CNS Tumors.
Cotter JA; Viaene AN; Santi M; Hawkins C; Judkins AR
Pediatr Dev Pathol; 2022; 25(1):6-9. PubMed ID: 33872110
[TBL] [Abstract][Full Text] [Related]
6. The World Health Organization Classification of Tumors of the Central Nervous System, Fifth Edition, 2021: A Critical Analysis.
Miller DC
Adv Tech Stand Neurosurg; 2023; 46():1-21. PubMed ID: 37318567
[TBL] [Abstract][Full Text] [Related]
7. World Health Organization 2016 Classification of Central Nervous System Tumors.
Diamandis P; Aldape K
Neurol Clin; 2018 Aug; 36(3):439-447. PubMed ID: 30072064
[TBL] [Abstract][Full Text] [Related]
8. The 2021 WHO Classification of Tumors of the Central Nervous System: a summary.
Louis DN; Perry A; Wesseling P; Brat DJ; Cree IA; Figarella-Branger D; Hawkins C; Ng HK; Pfister SM; Reifenberger G; Soffietti R; von Deimling A; Ellison DW
Neuro Oncol; 2021 Aug; 23(8):1231-1251. PubMed ID: 34185076
[TBL] [Abstract][Full Text] [Related]
9. Shedding Light on the 2016 World Health Organization Classification of Tumors of the Central Nervous System in the Era of Radiomics and Radiogenomics.
Colen RR; Hassan I; Elshafeey N; Zinn PO
Magn Reson Imaging Clin N Am; 2016 Nov; 24(4):741-749. PubMed ID: 27742114
[TBL] [Abstract][Full Text] [Related]
10. Mesenchymal non-meningothelial tumors of the central nervous system: a literature review and diagnostic update of novelties and emerging entities.
Tauziède-Espariat A; Hasty L; Métais A; Varlet P
Acta Neuropathol Commun; 2023 Feb; 11(1):22. PubMed ID: 36737790
[TBL] [Abstract][Full Text] [Related]
11. Adult Diffuse Astrocytic and Oligodendroglial Tumors.
Gestrich CK; Couce ME; Cohen ML
Neurosurgery; 2021 Oct; 89(5):737-749. PubMed ID: 33611566
[TBL] [Abstract][Full Text] [Related]
12. [Neuropathology of pediatric brain tumors : Implications of the 5th edition of the WHO classification of central nervous system tumors].
Reyes Medina B; Wrede A; Schulz-Schaeffer WJ
Radiologie (Heidelb); 2023 Aug; 63(8):577-582. PubMed ID: 37477671
[TBL] [Abstract][Full Text] [Related]
13. Molecular neuropathology: an essential and evolving toolbox for the diagnosis and clinical management of central nervous system tumors.
Bertero L; Mangherini L; Ricci AA; Cassoni P; Sahm F
Virchows Arch; 2024 Feb; 484(2):181-194. PubMed ID: 37658995
[TBL] [Abstract][Full Text] [Related]
14. New Classification for Central Nervous System Tumors: Implications for Diagnosis and Therapy.
Fuller CE; Jones DTW; Kieran MW
Am Soc Clin Oncol Educ Book; 2017; 37():753-763. PubMed ID: 28561665
[TBL] [Abstract][Full Text] [Related]
15. The 2007 WHO classification of tumors of the central nervous system - what has changed?
Rousseau A; Mokhtari K; Duyckaerts C
Curr Opin Neurol; 2008 Dec; 21(6):720-7. PubMed ID: 18989119
[TBL] [Abstract][Full Text] [Related]
16. WHO 2021 and beyond: new types, molecular markers and tools for brain tumor classification.
Tran S; Bielle F
Curr Opin Oncol; 2022 Nov; 34(6):670-675. PubMed ID: 36093875
[TBL] [Abstract][Full Text] [Related]
17. WHO CNS5 2021 classification of gliomas: a practical review and road signs for diagnosing pathologists and proper patho-clinical and neuro-oncological cooperation.
Sejda A; Grajkowska W; Trubicka J; Szutowicz E; Wojdacz T; Kloc W; Iżycka-Świeszewska E
Folia Neuropathol; 2022; 60(2):137-152. PubMed ID: 35950467
[TBL] [Abstract][Full Text] [Related]
18. Molecular diagnostics in central nervous system tumors.
Fuller CE; Perry A
Adv Anat Pathol; 2005 Jul; 12(4):180-94. PubMed ID: 16096380
[TBL] [Abstract][Full Text] [Related]
19. WES data from 286 diffuse gliomas under the 2021 WHO Classification of Tumors of the Central Nervous System.
Zhao Z; Zhang KN; Sun Z; Yang C; Wang Q; Li G; Wang Z; Zeng F; Chai R; Qian Z; Wang Z; Liu Y; Ma W; Wu F; Jiang T
Sci Data; 2022 Nov; 9(1):692. PubMed ID: 36369198
[TBL] [Abstract][Full Text] [Related]
20. Clinical Laboratory Testing Practices in Diffuse Gliomas Prior to Publication of 2021 World Health Organization Classification of Central Nervous System Tumors.
Ramkissoon SH; Fernandes H; Lopez-Terrada DH; Hameed MR; Trembath DG; Bridge JA; Lindeman NI; Souers RJ; Vasalos P; Brat DJ; Moncur JT
Arch Pathol Lab Med; 2022 May; 147(5):518-524. PubMed ID: 35878398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
